American State Bank (Iowa)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,601
Closed -$204K 145
2026
Q1
$204K Sell
1,601
-318
-17% -$39.7K 0.1% 134
2025
Q4
$234K Buy
+1,919
New +$220K 0.11% 129
2024
Q1
Sell
-2,381
Closed -$213K 326
2023
Q4
$213K Hold
2,381
0.14% 124
2023
Q3
$174K Hold
2,381
0.12% 128
2023
Q2
$198K Sell
2,381
-39
-2% -$3.26K 0.14% 122
2023
Q1
$184K Buy
2,420
+270
+13% +$22.4K 0.13% 127
2022
Q4
$178K Hold
2,150
0.14% 122
2022
Q3
$171K Buy
2,150
+37
+2% +$3.12K 0.15% 120
2022
Q2
$157K Buy
2,113
+465
+28% +$34.9K 0.12% 128
2022
Q1
$148K Hold
1,648
0.1% 143
2021
Q4
$185K Buy
1,648
+285
+21% +$34.4K 0.13% 132
2021
Q3
$171K Hold
1,363
0.13% 128
2021
Q2
$185K Buy
1,363
+88
+7% +$11.6K 0.14% 123
2021
Q1
$173K Sell
1,275
-37
-3% -$5.54K 0.15% 123
2020
Q4
$185K Buy
+1,312
New +$168K 0.18% 114

Other funds holding XBI

American State Bank (Iowa)'s XBI Position: Q2 2026 in Review

American State Bank (Iowa) sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2026, closing a stake of 1,601 shares — an estimated $204K sold.

American State Bank (Iowa) first reported a position in XBI in Q4 2020 and held it in 15 quarters. The position peaked at $234K in Q4 2025. 306 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • American State Bank (Iowa) reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2026 after selling out during the quarter.
  • American State Bank (Iowa) sold 1,601 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $204K.
  • American State Bank (Iowa) first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and held it in 15 quarters.
  • American State Bank (Iowa)'s State Street SPDR S&P Biotech ETF position peaked at $234K in Q4 2025.
  • 306 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on American State Bank (Iowa)'s 13F filing for Q2 2026, filed 9 Jul 2026.